Abstract:Every cell is covered with a dense layer of glycans, which is termed glycocalyx. The outermost monosaccharide of these glycans is often sialic acid, which are a family of nine-carbon monosaccharides. Sialylated glycans play important roles in various physiological and pathological processes, including pathogen invasion, cancer progress, and immune response. Lectins and antibodies have long been used for labeling and detecting sialylated glycans. However, they suffer from low affinity and poor specificity. In the past decades, metabolic glycan labeling (MGL) has emerged as a powerful tool for probing sialylation in live cells and living animals. In the MGL strategy, unnatural sugars containing a bioorthogonal functional group is metabolically incorporated into sialylated glycans by exploiting the underlying glycan biosynthetic pathway. Subsequent bioorthogonal reactions enable conjugation of sialylated glycans with imaging probes or enrichment tags. In this review, we first give a brief introduction on the history and current progress of MGL and bioorthogonal chemistry. Secondly, we discuss the application of MGL in the studies of dynamic changes and regulation of sialylation in various biological processes. Several examples from our research group on the studies of sialylation dynamics in epithelial-mesenchymal transition (EMT), neuronal stem cell differentiation, and cardiac hypertrophy are presented. By metabolic labeling of sialoglycans with ManNAz during EMT, we observed that cellular sialylation was downregulated during EMT, followed by reversion and upregulation. In neuronal stem cells, metabolic labeling of cell-surface sialoglycans has been exploited to discover cell-surface markers. Sialylation in cardiac hypertrophy was investigated by MGL in intact rat hearts, which revealed upregulation of sialylation during hypertrophy. Thirdly, aiming to expand the applications of MGL, we have developed new methods for protein-specific glycan imaging, cell- and tissue-selective glycan labeling, glycan Raman imaging, and novel unnatural sugars. By combining MGL with site-specific protein labeling, we developed a cis-membrane FRET-based methodology to visualize glycans of specific proteins of interest on live cells. Using the protein-specific glycan imaging technique, we found that sialylation of α X β 2 integrin is important for its activation. To overcome the limitation that MGL lacks cell-type selectivity, we developed the liposome-assisted bioorthogonal reporter (LABOR) strategy, in which azido sialic acid is encapsulated in ligand-targeted liposomes for cell-selective labeling of sialylated glycans via the receptor-mediated endocytosis. We demonstrated the LABOR strategy by selective labeling of sialoglycans in folate receptor-overexpressed cells. LABOR enables targeted imaging of tumor-associated sialoglycans and brain sialoglycans in living mice. Fourthly, novel unnatural sialic acids have been developed for probing specific sialoglycoforms, identifying sialic acid-binding proteins, remodeling cell-surface sialic acid, and bioorthogonal Raman imaging of sialylated glycans. Finally, we give an outlook on future directions of studying sialobiology using these chemical methods.

Protein S-Glyco-Modification Through an Elimination-Addition Mechanism

Imaging of protein-specific glycosylation by glycan metabolic tagging and in situ proximity ligation.

Artificial Cysteine S‐Glycosylation Induced by Per‐O‐Acetylated Unnatural Monosaccharides During Metabolic Glycan Labeling

Investigation of Relationships Between Metabolic Chemical Reporter Structures and S-glyco-modification Effects

Longer fatty acid-protected GalNAz enables efficient labeling of proteins in living cells with minimized S -glyco modification

Metabolic Glycan Labeling in Primary Neurons Enabled by Unnatural Sugars with No S-Glyco-Modification.

Chemical Labeling and Analysis of Sialoglycans

Unexpected tolerance of glycosylation by UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase revealed by electron capture dissociation mass spectrometry: carbohydrate as potential protective groups

Protection-Free Site-Directed Peptide or Protein S -Glycosylation and Its Application in the Glycosylation of Glucagon-like Peptide 1

Nonenzymatic Stereoselective S -Glycosylation of Polypeptides and Proteins

Bioorthogonal Chemical Labeling Probes Targeting Sialic Acid Isomers for N-Glycan MALDI Imaging Mass Spectrometry of Tissues, Cells, and Biofluids

Non-enzymatic Stereoselective S-glycosylation of Polypeptides and Proteins

Rapid probing of sialylated glycoproteins in vitro and in vivo via metabolic oligosaccharide engineering of a minimal cyclopropene reporter

Facile Synthesis of Clickable Unnatural Sugars in the Unprotected and 1,6-Di-o-acylated Forms for Metabolic Glycan Labeling.

Nonenzymatic Stereoselective <i>S</i>-Glycosylation of Polypeptides and Proteins

Methylamidation for sialoglycomics by MALDI-MS: a facile derivatization strategy for both α2,3- and α2,6-linked sialic acids.

The Metabolic Chemical Reporter Ac46AzGal Could Incorporate Intracellular Protein Modification in the Form of UDP-6AzGlc Mediated by OGT and Enzymes in the Leloir Pathway

Expanding the repertoire of GalNAc analogues for cell-specific bioorthogonal tagging of glycoproteins

Stereoselective Alkyl C -Glycosylation of Glycosyl Esters via Anomeric C-O Bonds Homolysis: Efficient Access to C -Glycosyl Amino Acids and C -Glycosyl Peptides

A sequential bioorthogonal dual strategy: ManNAl and SiaNAl as distinct tools to unravel sialic acid metabolic pathways

Site‐Specific Protein Modification with Reducing Carbohydrates